Evaluation of direct in-vitro effect of Vaccinium macrocarpon against E. coli in urinary tract infection patients

Paper Details

Research Paper 01/12/2016
Views (642)
current_issue_feature_image
publication_file

Evaluation of direct in-vitro effect of Vaccinium macrocarpon against E. coli in urinary tract infection patients

Sardar Riaz-Ul-Hassan, Zeeshan Anjum, Nazia Malik, Lubna Shakir, Ghazanfar Ali
Int. J. Biosci. 9(6), 440-445, December 2016.
Copyright Statement: Copyright 2016; The Author(s).
License: CC BY-NC 4.0

Abstract

Cranberry extract is a famous crude drug used in urinary tract infection all over the world and research is being carried out on its different aspects in urinary tract infection treatment. In patient with recurrent urinary tract infection and prophylaxis use of anti-microbial is required for prolong period. It is an effective way but on the cost of adverse effects and increasing resistance among uro-pathogens has pursued the researchers to dig out other alternative anti-microbial agents for treatment of recurrent urinary tract infection. This fact has created interest in Cranberry (Vaccinium macrocarpon) for its use in recurrent urinary tract infection. One hundred patients from two hospitals were studied. Using well diffusion method E. coli resistance against Cranberry was checked in-vitro. E. coli showed resistance against CB extract powder in both centers. Cranberry has no direct effect on E. coli but its effectiveness in urinary tract infection along with antibiotics is due to its anti-motility, anti-adherence effects.

Acharya A, Gautam R, Subedee L. 2011. Uropathogens and their antimicrobial susceptibility pattern in Bharatpur, Nepal. Nepal Med Coll J 13, 30-33.

Akortha E, Ibadin O. 2008. Incidence and antibiotic susceptibility pattern of Staphylococcus aureus amongst patients with urinary tract infection (UTI) in UBTH Benin City, Nigeria. African Journal of Biotechnology 7.

Bilgic D, Beji NK. 2010. Lower urinary tract symptoms in women and quality of life. International Journal of Urological Nursing 4, 97-105.

Blatherwick N. 1914. The specific role of foods in relation to the composition of the urine. Archives of Internal Medicine 14, 409-450.

Blatherwick N, Long ML. 1923. Studies of urinary acidity II. The increased acidity produced by eating prunes and cranberries. Journal of biological chemistry 57, 815-818.

Bodel PT, Cotran R, Kass EH. 1959. Cranberry juice and the antibacterial action of hippuric acid. The Journal of laboratory and clinical medicine 54, 881-888.

Brooks D. 1990. The management of suspected urinary tract infection in general practice. Br J Gen Pract 40, 399-401.

Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. 2000. Urinary tract infection: self-reported incidence and associated costs. Annals of epidemiology 10, 509-515.

Gupta K, Chou M, Howell A, Wobbe C, Grady R, Stapleton A. 2007. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. The Journal of urology 177, 2357-2360.

Hidalgo G, Chan M, Tufenkji N. 2011. Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. Applied and environmental microbiology 77, 6852-6857.

Hisano M, Bruschini H, Nicodemo AC, Srougi M. 2012. Cranberries and lower urinary tract infection prevention. Clinics 67, 661-668.

Howell AB. 2007. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Molecular nutrition & food research 51, 732-737.

Lane DR, Takhar SS. 2011. Diagnosis and management of urinary tract infection and pyelonephritis. Emergency medicine clinics of North America 29, 539-552.

Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A, 2008. In vitro and in vivo evidence of dose dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clinical Microbiology and Infection 14, 350-355.

Liu Y, Black MA, Caron L, Camesano TA. 2006. Role of cranberry juice on molecular scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol. Bioeng. 93, 297-305.

Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M. 2014. Cranberry and recurrent cystitis: more than marketing? Critical reviews in food science and nutrition 54, 1063-1075.

Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. 2011. Urinary tract infections in women: etiology and treatment options. Int J Gen Med 4, 333-343.

Moen D. 1962. Observations on the effectiveness of cranberry juice in urinary infections. Wisconsin medical journal 61, 282-283.

Nicolle LE. 2008. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urologic Clinics of North America 35, 1-12.

Pérez-López FR, Haya J, Chedraui P. 2009. Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits. Journal of Obstetrics and Gynaecology Research 35, 630-639.

Raz R, Chazan B, Dan M. 2004. Cranberry juice and urinary tract infection. Clinical infectious diseases 38, 1413-1419.

Sharma D, Tiwari S. 2012. Use of cranberry in Urinary Tract Infection of E. coli. International Journal of Pharmacy & Life Sciences 3.

Toromanović¹ J, Kovač-Bešović E, Šapčanin A, Tahirović¹ I, Rimpapa Z. 2008. Urinary hippuric acid after ingestion of edible fruits. Bosnian Journal of Basic Medical Sciences 8, 38-43.

Ullah F, Malik S, Ahmed J. 2009. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. African Journal of Biotechnology 8.

Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. 1989. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrobial agents and chemotherapy 33, 92-98.

Related Articles

Medicinal plants sold in Daloa markets: Traditional knowledge and Public health issues

Kouakou Yao Bertin, Kouakou Assoman Serge Alain, Kouame Yao Anicet Gervais, Malan Djah François, Bakayoko Adama, Int. J. Biosci. 27(2), 200-210, August 2025.

Agronomic performance and profitability of coffee wildlings using different soil media mixtures

Maribel L. Fernandez, Ricardo B. Casauay, Ronel A. Collado, Int. J. Biosci. 27(2), 189-199, August 2025.

Implications of aberrant glycosylation on age-related disease progression

Tahmid Ahmad Patwary, Mukramur Rahman, Md. Nafis Fuad Prottoy, Sayad Md. Didarul Alam, Int. J. Biosci. 27(2), 176-188, August 2025.

Design and development of solar powered water sprayer: A green technology innovation

Lorenzo V. Sugod, Int. J. Biosci. 27(2), 159-175, August 2025.

Knowledge, attitudes, practices, and social awareness regarding SARS-CoV-2 infection in the kyrgyz population in the post-pandemic period

Mirza Masroor Ali Beg, Haider Ali, Yahya Nur Ahmed, Yavuz Gunduz, Hafsa Develi, Tilekeeva UM, Int. J. Biosci. 27(2), 151-158, August 2025.

Tumor suppressing ability of myrtenal in DMBA-induced rat mammary cancer: A biochemical and histopathological evaluation

Manoharan Pethanasamy, Shanmugam M. Sivasankaran, Saravanan Surya, Raju Kowsalya, Int. J. Biosci. 27(2), 141-150, August 2025.

Assessing tree diversity in cashew plantations: Environmental and agronomic determinants in buffer zones of Mont Sangbé National Park, western Côte d’Ivoire

Kouamé Christophe Koffi, Kouakou Hilaire Bohoussou, Serge Cherry Piba, Naomie Ouffoue, Sylvestre Gagbe, Alex Beda, Adama Tondossama, Int. J. Biosci. 27(2), 122-133, August 2025.